Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Kim et al., Nature Communications, 2019, 10:4898, doi.org/10.1038/s41467-019-12910-2 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Pavlova et al., J. Virol., Feb 2013; 87: 2011 - 2022 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R. Martínez-Mármol, Scientific Reports, 7:42395, DOI: 10.1038/srep42395 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Breit et al., J. Biol. Chem., Dec 2006; 281: 37447 - 37456 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K4 Transfection System | publication | A.Y. Benkherouf et al., Activity. Front. Neurosci., 2020, 14: 594708, doi: 10.3389/fnins.2020.594708 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Schulz et al., Scientific Reports, 2018, 8: 2395, DOI:10.1038/s41598-018-19201-8 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | M. F. Fjelldal et al., Pharmacol. Res. Perspect., 2019, e00480, DOI: 10.1002/prp2.480 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | Z. Cao et al., Traffic., 2019, 20: 357–368, doi: 10.1111/tra.12642 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene PRO | publication | A. Lünemann et al., J. Immunol., Nov 2013; 191: 4989 - 4995 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene PRO | publication | M. N. Garas et al., Acta naturae, 2014, 6, 2(21): 95-105 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | V. Ravarotto, PhD Thesis, 2018, Universita degli Studi di Padova | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Shin et al., Mol. Cell. Biol., Dec 2007; 27: 8113 - 8126 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J. Haar et al., Nucleic Acids Res., Feb 2016; 44: 1326 - 1341 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Timsah et al., Nature Struct. & Mol. Biol., 2014, 21(2), doi:10.1038/nsmb.2752 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | H.-K. Lee et al., J. Biol. Chem., Oct 2014; 289: 28225 - 28236 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | bacmid | virusproduction | Metafectene | publication | D. G. van Zyl, Dissertation, 2018, Ruperto-Carola University of Heidelberg | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene EASY | publication | T.I. Kopp et al., Human and Experimental Toxicology, Nov 2015; 34: 1106 - 1118 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | W. I. DeHaven et al., J. Physiol., 2009, 587.10, 2275-2298 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | N. Kawai et al., Eur. J. Biochem. 270, 4459-4468 (2003) | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | O. N. Kuvardina et al., Blood, Jun 2015; 125: 3570 - 3579 |